4//SEC Filing
ORAMED PHARMACEUTICALS INC. 4
Accession 0001140361-14-005083
$ORMPCIK 0001176309operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:54 PM ET
Size
20.2 KB
Accession
0001140361-14-005083
Insider Transaction Report
Form 4
REGALS CAPITAL MANAGEMENT LP
10% Owner
Transactions
- Purchase
Common Stock
2014-02-05$16.32/sh+24,492$399,798→ 1,349,585 total(indirect: See) - Purchase
Common Stock
2014-02-06$14.96/sh+26,800$400,941→ 1,376,385 total(indirect: See)
Regals Fund LP
10% Owner
Transactions
- Purchase
Common Stock
2014-02-05$16.32/sh+24,492$399,798→ 1,349,585 total(indirect: See) - Purchase
Common Stock
2014-02-06$14.96/sh+26,800$400,941→ 1,376,385 total(indirect: See)
Slager David Mark
10% Owner
Transactions
- Purchase
Common Stock
2014-02-05$16.32/sh+24,492$399,798→ 1,349,585 total(indirect: See) - Purchase
Common Stock
2014-02-06$14.96/sh+26,800$400,941→ 1,376,385 total(indirect: See)
Footnotes (2)
- [F1]Regals Capital Management LP, a Delaware limited partnership ("Regals Management"), the Fund, and David M. Slager ("Mr. Slager"), are the reporting persons (the "Reporting Persons") for the referenced securities. Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The shares of the issuer's common stock reported herein are held for the account of the Fund.
- [F2]As a result, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001176309
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:54 PM ET
- Size
- 20.2 KB